Lyra Therapeutics (LYRA) Earnings Date, Estimates & Call Transcripts $8.55 +0.02 (+0.23%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$8.55 0.00 (0.00%) As of 06:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Earnings Summary Lyra Therapeutics announced Q1 2025 earnings on May 6, 2025, reporting an EPS of -$6.00, which topped the consensus estimate of -$7.50 by $1.50. Quarterly revenue was reported to be $0.18 million, above analyst estimates of $0.16 million. With a trailing EPS of -$60.50, Lyra Therapeutics' earnings are expected to grow next year, from ($0.93) to ($0.58) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 6) -$7.50 Actual EPS (May. 6) -$6.00 Beat By $1.50 Actual Revenue (May. 6) $0.18MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)LYRA Upcoming EarningsLyra Therapeutics' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Friday, August 8, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Lyra Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lyra Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLYRA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LYRA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Lyra Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$6.00-$6.00-$6.00Q2 20252-$7.03-$6.00-$6.52Q3 20252-$8.87-$6.00-$7.44Q4 20252-$11.17-$8.00-$9.59 Lyra Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/6/2025Q1 2025-$7.50-$6.00+$1.50-$0.13$0.16M$0.18M3/13/2025Q4 2024-$6.00-$8.00 -$2.00-$0.16$0.21M$0.21M8/14/2024Q2 2024-$17.00-$14.50+$2.50$0.16$0.43M$0.60M4/30/2024Q1 2024-$13.00-$17.50 -$4.50-$0.35$0.40M$0.53M3/21/2024Q4 2023-$16.50-$11.00+$5.50-$0.22$0.52M$0.15M11/7/2023Q3 2023-$16.50-$13.50+$3.00-$0.27$0.48M$0.54M8/8/2023Q2 2023-$22.00-$16.50+$5.50-$0.30$0.41M$0.46M Lyra Therapeutics Earnings - Frequently Asked Questions When is Lyra Therapeutics' earnings date? Lyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on LYRA's earnings history. Did Lyra Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lyra Therapeutics (NASDAQ:LYRA) reported ($6.00) earnings per share (EPS) to beat the analysts' consensus estimate of ($7.50) by $1.50. Learn more on analysts' earnings estimate vs. LYRA's actual earnings. How much revenue does Lyra Therapeutics generate each year? Lyra Therapeutics (NASDAQ:LYRA) has a recorded annual revenue of $1.53 million. How much profit does Lyra Therapeutics generate each year? Lyra Therapeutics (NASDAQ:LYRA) has a recorded net income of -$93.43 million. LYRA has generated -$60.50 earnings per share over the last four quarters. What is Lyra Therapeutics' EPS forecast for next year? Lyra Therapeutics' earnings are expected to grow from ($0.93) per share to ($0.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies Titan Medical Earnings Vivos Therapeutics Earnings Nephros Earnings Modular Medical Earnings Precision Optics Earnings NeuroOne Medical Technologies Earnings PolyPid Earnings Envoy Medical Earnings DarioHealth Earnings Femasys Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Citigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting Cycle This page (NASDAQ:LYRA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat’s the “Golden Anomaly”… and how can you profit?Trump’s “Big Beautiful Bill” passed! That means the US is on track for $60 trillion in debt by 2035 – by the g...Golden Portfolio | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
